Scientists from the RECNAC II project have Published findings that verify the safety of high Dose intravenous Vitamin C. In this study, published in the Puerto Rico Health Sciences Journal, a phase one clinical trial with 24 terminal Cancer Patients receiving between ten and sixty grams of sodium ascorbate daily for eight weeks, adverse effects were reportedly minor.

"The results presented in this manuscript should allay fears about the safety of 'mega-dose' vitamin C," said Dr. Joseph Casciari, co-author of the manuscript.

Read the full story here